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Fusion peptides are hydrophobic and conserved sequences located within glycoprotein ectodomains that protrude from the virion surface.
Direct participation of fusion peptides in the viral membrane fusion phenomenon has been inferred from genetic analyses showing that even a
single residue substitution or a deletion within these sequences may completely block the process. However, the specific fusion peptide
activities associated to the multi-step fusion mechanism are not well defined. Based on the assumption that fusion peptides are transferred
into target membranes, biophysical methodologies have been applied to study integration into model membranes of synthetic fragments
representing functional and non-functional sequences. From these studies, it is inferred that, following insertion, functional sequences
generate target membrane perturbations and adopt specific structural arrangements within. Further characterization of these artificial systems
may help in understanding the molecular processes that bring initial bilayer destabilizations to the eventual opening of a fusion pore.D 2003 Elsevier B.V. All rights reserved.Keywords: Viral membrane fusion; Fusion peptide; Peptide– lipid interaction; HIV-1 gp41; Influenza HA2; SFV E11. Introduction
The presence of a fusion peptide (FP) within the ecto-
domain exposed to the external aqueous medium is a salient
feature of viral fusion proteins [1–6]. These hydrophobic
sequences, usually located at the N-terminal end of the
fusogenic transmembrane subunit, or close to it, are thought
to be involved in driving the initial partitioning of the fusion
protein into the target membrane. Hence, at a certain stage
after fusion activation, the cryptic FP is exposed and likely
to insert into the lipid bilayer of the target cell, thus
transiently making the viral envelope glycoprotein an inte-
gral component of two membranes: that of the virus and that
of the target cell [7–10]. Indeed, membrane insertion of FPs
within the context of the whole fusion glycoprotein has been0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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techniques [11].
Amino acid homology between fusion proteins of differ-
ent viruses is usually of less than 20%. In contrast, FP
homology for the same proteins can be as high as 90% [1].
FPs are also unusually enriched in Ala and Gly residues
[3,4,6]. Comparable high degrees of residue conservation
and Ala/Gly content are not found in other membrane-
associated hydrophobic protein domains as signal sequences
or transmembrane anchors, suggesting that FP sequences
have evolved constrained by a selective pressure that cannot
be explained by simple requirements of hydrophobicity or
amphipathicity. Indeed, mutational analyses have estab-
lished an absolute requirement for certain residues at de-
fined positions [12,13], although this might not be the
general case (see Ref. [14]).
No consensus exists as yet on the roles played by FPs in
viral fusion. Some authors suggest that these sequences
constitute the ‘‘active center’’ of the fusogenic protein
molecule. According to this hypothesis, FPs would directly
mediate fusion of the viral envelope with a cellular mem-
brane [7,15]. Information available on the low-energy struc-
tures of human immunodeficiency virus (HIV)-1 gp41 and
influenza HA2 glycoprotein ectodomains suggests that FPs
would be linked through flexible tethers to helical domains
[15,16]. Thus FPs need not be linked to those a-helices to
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activity depends solely on the intrinsic capacity of FPs to
disrupt the target bilayer architecture after insertion.
An alternative hypothesis states that FPs would function
as inert anchors, i.e., ‘‘secondary’’ transmembrane domains
(TMDs) translocated into the target membrane by the action
of the fusion glycoprotein [17]. Thus, upon fusion activa-
tion, FPs and ‘‘primary’’ TMDs would tightly tether target
cell and viral membranes, respectively. Fusion would sub-
sequently evolve, directly coupled to the collapse that
follows formation of the low-energy helical bundle [17–
20]. However, both proposed FP action mechanisms need
not be mutually exclusive [21]. Mutant fusion domains have
been isolated that are capable of integrating into target
bilayers, and yet they do not support fusion activity
[12,22], indicating that simple insertion is not enough to
unleash FP function. Moreover, a direct role of FPs at
facilitating fusion pore formation has been described [22–
24], further suggesting the existence of unknown functional
membrane-bound structures of FPs.
As discussed by Epand et al. [25] many features of the
complex viral systems are not present in isolated peptide–
vesicle model systems. In the context of the full-length
envelope protein, FPs are linked to other sequences that may
condition their conformational behavior. Natural target
membranes bear specific characteristics such as composition
(presence of particular lipids and proteins) and asymmetry
that are difficult to reproduce in vitro. FP cooperativity
might as well be promoted through oligomerization of
protein complexes and/or by the high local concentrations
already present at the viral envelope. Nevertheless, analysis
of the molecular mechanisms underlying FP activity in the
whole protein would be in most cases not viable. This has
justified the development of in vitro FP assays using
representative synthetic peptides and model membranes.2. Evaluation of synthetic FP interaction with
membranes
Synthetic FPs have been assayed for their capacity to
perturb natural membranes. A good correlation has been
observed between the ability of a particular sequence to
support fusion in the intact protein and its ability to induce
hemolysis [13,26,27]. In addition, HIV-1 FP has been
shown to induce cytolysis of viral target CD4+ lymphocytes,
and fusion of erythrocytes [28–30]. An advantage of using
natural membranes is that their compositions and asymme-
try approximate those present in the viral target bilayers.
However, specific effects of the lipid environment on FP
activity have been more widely analyzed using lipid model
systems of defined structure and composition. Large uni-
lamellar vesicles (LUV) represent bilayer systems that
closely resemble the lipid packing density and curvature
corresponding to biological membranes. In contrast, highly
curved small unilamellar vesicles (SUV) produced by son-ication mimic the conditions of stressed bilayers as found in
certain physiological instances. In addition, phospholipid
monolayer systems allow the selection of defined packing
density conditions and, therefore, the assessment of lateral
pressure effects on the ability of peptides to penetrate the
membranes. This option suits the study of FPs particularly
well since their interaction appears to be initially restricted
to the external monolayer of the target membrane [31–33].
Molecular interactions of FPs with model membranes
may be investigated at several stages. First, membrane
association is limited by the capacity of the sequence to
partition from the aqueous to the membrane phase. Once
membrane association is accomplished, peptides attain char-
acteristic locations, conformations and degrees of oligomer-
ization that are thought to condition subsequent induction of
bilayer perturbations such as permeabilization or fusion.
2.1. FP transfer to membranes
It is generally assumed that FPs transfer from the
aqueous medium to membranes due to spontaneous parti-
tioning. Their tendency to partition from water into mem-
branes is already suggested by their high interfacial
hydrophobicity [5,34–36]. When synthetic FPs are diluted
in water, aggregation usually occurs due to their hydropho-
bic character. Under most experimental conditions, aggre-
gation in solution proceeds more slowly than membrane
binding, thereby allowing effective incorporation of pep-
tides into target membranes. However, formation of pep-
tide aggregates precludes the experimental characterization
of the water–membrane peptide partitioning equilibrium
[34,37,38].
Determining the thermodynamic parameters governing
this equilibrium might be useful to compute the amount of
free energy that could effectively be coupled to membrane
merging. This problem has been recently approached by
Han and Tamm [37,38] using HA FPs linked to positively
charged and unstructured sequences that solubilize the entire
constructs. These authors determined an experimental value
of  7.6 kcal mol 1 for the free energy of partitioning of
the 20-aa-long influenza FP into SUVs at pH 5.0. Consid-
ering 60–120 kcal mol 1 as the free energy for the
formation of highly curved lipidic structures that initially
mediate membrane merging (see below), it was concluded
that binding of 8–16 FPs would provide sufficient energy to
stabilize such an intermediate. These calculations would
therefore support a necessary and sufficient role of FPs at
promoting viral membrane fusion.
2.2. FP insertion into membranes
The relevance of membrane-bound FP structures for viral
fusion is supported by the fact that fragmented transmem-
brane oligomers can reassemble in specific ways (discussed
in Ref. [39]). Thus spontaneous FP assembly into model
membranes may also reflect the early events that mediate FP
Fig. 1. Membrane-embedded low-pH structure of influenza HA FP:
GLFGAIAGFIENGWEGMIDG [33]. Side chains and backbone corre-
sponding to residues identified as affecting peptide–membrane interaction
and fusion are indicated in red. (1) Gly1: polar substitutions or deletions
abolish HA fusion activity and FP-induced hemolysis. Ala sustains activity
while Ser induces ‘‘hemifusion’’ phenotype. Polar G1E substitution impairs
membrane penetration and permeabilization, and promotes h-strand
formation. Bulkier hydrophobes do not support activity. G1V inserts
perpendicular to membrane plane. (2) Gly4: G4E shows reduced activity,
synthetic G4E FPs associate to membranes with lower affinity. (3) Ala5:
A5V, but not A5G, blocks HA-induced fusion and FP-induced hemolysis,
secondary FP structure does not appear to be affected. (4) Ala7: A7G, but
not A7V, blocks HA-induced fusion and FP-induced hemolysis, secondary
FP structure appears not to be affected. (5) Gly8: in this position Ala does
not support HA activity, G8A peptide does not induce hemolysis. (6) Glu11
and Glu14: Val residues in these positions support fusion, enhance RBC
lysis and promote more effective membrane penetration at neutral pH.
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picture has emerged for the structures of monomeric mem-
brane-bound HIV-1 and HA FPs. Based on electron spin
resonance data, Gordon et al. [40] assumed the existence of
an a-helical monomeric transmembrane state of HIV-1 FP
with the N-terminus embedded in the bilayer core. The
molecular model developed for this monomeric state by the
same authors [40,41] and the NMR structure calculated by
Chang et al. [42,43] for the peptide solubilized by SDS,
concur in proposing the insertion of residues 1–15 in an a-
helical conformation, and the existence of a flexible hinge
Ala15–Gly16 that causes redirectioning of the C-terminal
sequence. In addition, polarized attenuated total reflection
infrared spectroscopy analysis by Martin et al. [44,45]
indicated that insertion of the a-helical stretch spanning
residues 1–16 occurs at an oblique angle.
Insertion of HA FP restricted to the external membrane
monolayer was demonstrated by Brunner [31] using asym-
metric hydrophobic photolabeling. This observation was
confirmed by spin-labeling electron paramagnetic resonance
[32]. According to the latter study, the N-terminus of HA FP
also penetrates into the membrane hydrophobic core. The
depth profile was consistent with an a-helix tilted from the
horizontal plane of the membrane with a maximum depth of
15 A˚ from the phosphate group. An oblique angle of
insertion was also revealed by polarized attenuated total
reflection infrared spectroscopy [46,47]. Combining NMR-
solved structures in micelles with EPR distance constraints
measured in LUV, Han et al. [33] deduced that a 20-mer HA
FP inserts into membranes in an ‘‘inverted V’’ conformation
(Fig. 1). At low pH, the structure inserts deeper while the C-
terminal arm transitions from an extended structure to a
shorter 310-helix. The low-pH-induced structural change is
proposed to intensify the FP capacity to distort bilayer
architecture. Even though somehow discordant interpreta-
tions of structural HA FP NMR data in micelles have been
reported [48–50], the ‘‘inverted V’’ model described by
Han et al. [33] might constitute a valuable paradigm for
future tests of the structural effects exerted by HA FP
mutations which interfere with fusion activity (Ref. [21],
see also Fig. 1).
2.3. FP oligomerization in membranes
It is generally accepted that viral fusion is promoted by
high order complexes or ring-like protein aggregates that
would confine fusion-inducing perturbations to localized
areas of the interacting bilayers [2,3,51,52]. The rules
governing specific self-association of protein stretches im-
mersed into the bilayer milieu are only partially understood
[39,53]. FPs have been shown to specifically self-associate
in the membrane suggesting that surface oligomerization
plays an important role in polypeptide-induced fusion [53–
55]. It has been proposed that FPs inserted into target
bilayers might assist recruitment of several fusion proteins
into a single fusion site [6,38].HIV-1 and HA FP self-association appear mediated by
predominantly extended (h-like) conformations [5,6,
35,38,56–61]. However, models of helical complexes for
membrane-embedded FPs have also been proposed [49]. In
particular, the HIV-1 FP has been suggested to alternate
membrane-bound a-helical and extended aggregates
depending on bilayer physicochemical parameters such as
lateral pressure or degree of surface hydration [56,57,62].
2.4. FP-induced bilayer perturbations
FPs inserted into the target membrane may cause the
distortion of bilayer organization that is necessary for rupture
and merging [25,63]. Viral FPs show lytic effects after
binding to either SUV or LUV (see below). In addition,
vesicle suspensions treated with these sequences may under-
go mixing of lipid components, an activity that may be a
correlate of virus-induced membrane fusion. A summary of
the lipid vesicle perturbations induced by HIV-1 FP is shown
as a function of time in Fig. 2. The earliest perturbation results
in leakage of vesicular contents. This is followed by vesicle
aggregation and eventual inter-vesicle mixing of lipids. It is
important however to discern the leakage of vesicle contents
that accompanies the transitional destabilization required for
Fig. 2. Typical time-courses of HIV-1 FP-induced vesicle perturbations. At
the time indicated by the arrow, the NH2-AVGIGALFLGFLGAAGSTM-
GARS-CONH2 peptide was added to a suspension of PC/PE/Chol (1:1:1)
LUV (100 AM) to a final peptide-to-lipid mole ratio of 1:25. L: leakage of
aqueous contents (ANTS/DPX assay); S: vesicle aggregation (increase in
scattered light with excitation and emission wavelengths set at 500 nm); F:
fusion (NBD/Rho assay). For better time-resolution, the perturbing effects
were slowed down by increasing the pH to 8.0 and by decreasing
temperature to 16 jC.
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process occurring through defined pore-like structures [5].
Thus, the HIV-1 FP has been shown to support a leakage
process that is not necessarily related to vesicle aggregation
or fusion [5,56,62]. The requirements of this process in
terms of number of peptides bound per vesicle and structure
adopted by the peptide appeared to be different as compared
to those exhibited by the fusion phenomenon [56,64]. It was
proposed that membrane perturbations leading to fusion
were mediated by FPs penetrating shallowly into the exter-
nal membrane monolayer and containing mainly extended
structures [35,59], while pore formation probably required
translocation of helices across the bilayer [56,62]. In the
light of newly proposed viral fusion mechanisms [65], the
functional relevance of both conflicting structures and
processes remains to be established.
It is also unclear whether viral fusion involves the
formation of defined lipidic intermediates as those mediat-
ing thermotropic lamellar-to-non-lamellar phase transitions
[63,66–68]. According to this theory of fusion, the process
would start with the formation of the ‘‘stalk’’, a transient
lipidic intermediate locally connecting the cis monolayers of
apposed flat membranes [51,52,66,67]. Stalk formation
requires local destabilization of the contacting monolayers
and exposure of hydrophobic groups. Stalk enlargement
appears facilitated in systems with intrinsic negative curva-
ture. The latter process is required for the formation of local
points of hemifusion. While hemifusion represents the
energetic barrier of fusion, rupture of the single bilayer
diaphragm in these intermediates would constitute the
kinetic barrier. The process would terminate with the for-
mation of low-energy fusion pores connecting the initially
separated aqueous environments.In principle, FPs might promote fusion by reducing the
stalk and local hemifusion formation energies, and/or by
accelerating the decay to fusion pore formation [66,67]. It
has been proposed that FPs may modulate the target
membrane polymorphism, and therefore promote fusion,
by inducing lateral stress in the hydrocarbon region of the
external monolayer and/or by selectively inducing an incre-
ment of its surface [59,66]. Viral FPs do indeed induce non-
lamellar phases at lower temperatures than observed in the
pure lipid system [63,66,69]. In addition, the inclusion of
FPs is known to drive lamellar-to-non-lamellar (HII) tran-
sitions towards the formation of bicontinuous inverted cubic
phases (QII) [70–72]. Siegel and Epand [73] have demon-
strated that FPs, in the concentration range of 2–7 mol%
(i.e., under conditions that might promote their self-associ-
ation), do not stabilize non-lamellar structures by reducing
the spontaneous radius of curvature of the host lipid. Based
on the fact that FPs may lower the membrane rupture
tension [74,75], Siegel and Epand [73] propose that a more
plausible mechanism of fusion–promotion under these
conditions could be the destabilization of bilayer dia-
phragms at hemifusion intermediates.3. Physiological relevance of FP studies in model systems
Significant correlations have been established between
the effects of FP mutations on the activity of whole fusion
proteins, and the effects displayed by the same sequence
alterations on the capacity of synthetic analogs to interact
with model membranes and perturb them. The significance
of the effects displayed in vitro by other physiologically
relevant factors affecting fusion activity such as optimal pH,
are still a subject of controversy. However, simple systems
meant for intracellular delivery, based on the use of FPs
have been shown to reproduce several features of the viral
entry events upon interaction with cells. These findings
support the notion of synthetic peptides being useful models
to study viral cell fusion.
3.1. Influenza HA peptides
Structural information at the atomic molecular level
available for influenza HA indicates the existence of at least
three FP structures: one in uncleaved HA0, one adopted as
the N-terminal end of proteolytically processed HA2, and
one adopted upon contact with lipids. In combination, these
structural requirements impose distinct sequence constraints
that are only now starting to be unraveled [13,76]. In what
follows, only residue substitutions identified as affecting
peptide–membrane interaction and subsequent fusion will
be discussed as a possible source of information relevant in
the understanding of FP structure–function relationships
(Fig. 1).
Gething et al. [22] found that HA2 G1E substitution
abolished cell–cell and RBC–cell fusion activity of ex-
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ciency and elevated the pH threshold for activation of the
process. E11G did not affect RBC–cell fusion but impaired
syncytium formation. None of these mutations significantly
altered the ability of HA to bind SUVs in a pH-dependent
fashion, indicating that anchoring the target bilayer might be
necessary but not sufficient for fusion to occur. Wharton et
al. [77] subsequently demonstrated in the SUV system that
variant peptides containing these fusion-impairing mutations
had fusion properties similar to those of the corresponding
entire HA molecules. Importantly, non-fusogenic peptides
still interacted with the membrane but did not cause leakage
of liposomal contents. Synthetic 7-aa-long GLFGAIC ana-
logs were subsequently analyzed in their capacity to insert
into planar bilayers and LUV [78]. Also in good correlation
with functional assays, when compared to the wt-represent-
ing peptide, a G1E mutant-representing sequence did not
induce conductance increase or release of vesicular contents
to the medium. The impairment was not so severe when the
substitution was made at position 4.
The effects of G1E and G4E substitutions were also
extensively studied by Rafalski et al. [79] using 20-mer
GLFGAIAGFIENGWEGMIDG peptides derived from in-
fluenza X31 strain, and comparing their ability to interact
with POPC monolayers, SUV and LUV. Only fusion-com-
petent wt- and G4E-like peptides inserted at low pH into
POPC membrane monolayers at lateral pressures higher than
those existing in biological membranes and unstrained large
vesicles. Accordingly, only these sequences effectively par-
titioned into and permeabilized LUV. In sharp contrast, the
peptide representing the G1E mutant was unable to penetrate
at low pH into monolayers at surface pressures existing in
large vesicles and natural membranes, but inserted above
pressures existing in the highly curved external monolayer of
strained SUV [80]. As predicted, the G1E peptide was
experimentally shown to associate efficiently with SUV
but not with LUV. In this case, the use of the unstrained
LUV was crucial to discriminate between peptides from
functional versus non-functional mutant proteins.
Rafalski et al. [79] found no inter-vesicle fusion promot-
ed by the HA peptides under conditions that allowed POPC
LUV leakage (i.e., at low-pH and with wt-like sequence).
The authors noted that for efficient peptide-induced fusion
of LUV, other requirements must be met in addition to
bilayer destabilization, specifically the formation of curved
lipidic geometries that mediate membrane merger. The
dynamics of these curved intermediate lipid structures
may be affected by the presence of FPs as discussed above
[73]. In fact, the use of lipid mixtures that can undergo
thermotropic non-lamellar phase formation made possible
the observation of HA FP-induced LUV fusion that was pH-
dependent and impaired by the blocking mutations (Nieva
and Wilschut, unpublished observations). Also in agreement
with these observations, Epand and Epand [81] and Epand
et al. [69] showed that wt-like FP impaired lamellar-to-non-
lamellar lipid phase transitions at neutral pH, while non-lamellar phase formation was promoted by the same peptide
at acidic pH. Most importantly, G1E and G4E peptides were
unable to promote such non-lamellar arrangements of the
lipids even at the low pH.
Mutagenesis studies were afterwards extended to address
FP requirements in terms of charge and length, and to
understand the significance of invariable Gly residues
present in the sequence [26]. Glu residues at positions 11
and 15 could be substituted by Val without affecting specific
HA fusion activity. Ala could substitute for Gly at positions
1 and 4, but not at position 8, without blocking HA
expression-induced cell–cell fusion. Bulkier hydrophobes
(Ile, Leu, Phe) or polar residues (His, Ser) at position 1
abrogated the fusion activity. Importantly, these results
correlated with the hemolytic activity displayed by synthetic
analogs of the mutant FPs in that only fusion-supporting
sequences induced hemolysis at low pH. It was concluded
that both a defined length and a specific N-terminal residue
may be necessary for a functional association of the FP with
lipid that will influence the efficiency of the fusion process.
The effect of N-terminal Gly substitution or deletion on
FP secondary structure and orientation was subsequently
studied by means of infrared spectroscopy [47]. Consistent
with shallower insertion into unstressed bilayers G1E and
DG1 variants displayed a larger h-strand content than the wt-
like variant. Conformations were not significantly affected
by lowering the pH. Interestingly, both a-helical and h-
strand segments oriented at oblique angles to the membrane
normal in mutant- and wt-like sequences. Also in accordance
with different abilities to penetrate into unstressed mem-
branes, measurements in micropipette-aspired giant unila-
mellar vesicles, showed that deletion of the G1 residue
resulted in impairment of low-pH dependent bilayer area
expansion and permeation induced by the wt-like sequence
[74]. This is in contrast with the Trp fluorescence emission
maximum shifts observed for G1E, DG1 and wt-like sequen-
ces in the presence of SUV, that seem to indicate a similar
degree of penetration into these highly curved vesicles for
the three variants [47]. A later study by Longo et al. [75]
showed that structural changes in synthetic native FP
sequences also altered insertion and membrane disruption.
Thus, N-terminal modifications lead to diminished insertion
and less propensity to pore formation, while carboxyamida-
tion enhanced both abilities. Results by Longo et al. [74,75]
are crucial to demonstrate that pore formation is an intrinsic
property of HA FP and not a mere consequence of mono-
layer area expansion due to transfer of mass to membranes.
These experiments also put forward an important feature of
the FP: its capacity to lower membrane rupture tension.
In a combined mutational and structural study conserved
Ala residues at positions 5 and 7 were doubly replaced with
Gly (smaller) and Val (bulkier) hydrophobes [27]. Only
A5G and A7V substitutions supported cell–cell fusion in
cells transfected with mutated HA genes. Similarly, only
synthetic peptides representing these mutant sequences
induced hemolysis at levels comparable to that displayed
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ciably alter the secondary structure and orientation of
membrane-bound sequences.
Analysis by Steinhauer et al. [26] also demonstrated that
acidic residues within the FP’s first 15 residues were not
required for function. A recent report has addressed the
question of the greater accessibility to the bilayer at neutral
pH of a FP variant containing the Glu residues at positions
11 and 14 replaced by Val [82]. A shift of ca. + 0.2 pH units
was observed in the ability of the more hydrophobic variant
to induce leakage in erythrocyte membranes as compared to
the parental wt-representing sequence. Other evidences were
provided by these authors indicating that the mutant-like
sequence was likely to penetrate deeper into lipid mem-
branes.
A mutational and functional study by Qiao et al. [24]
revealed that blocking phenotypes at position 1 in influenza
FP were related to the side-chain volume of the particular
residues. Only nonpolar small Gly and Ala residues sup-
ported lipid and aqueous content mixing, while small polar
Ser displayed an only-lipid-mixing or hemifusion phenotype.
Bulkier hydrophobic (Val), polar (Gln) and charged residues
(Glu, Lys) completely impaired fusion activity. A recent
report has clarified several effects of these substitutions on
the ability of synthetic FPs to interact with and perturb
membranes [69]. A good correlation was found between
the ability of peptides to decrease lamellar-to-hexagonal (II)
lipid phase transition temperature and their ability to support
fusion as part of the intact HA. These measurements corre-
lated better with function than formation of isotropic non-
lamellar phases or inter-vesicle mixing of lipids induced by
the peptides. The particular case of G1V substitution pro-
duced a peptide that inserted perpendicular to the membrane
plane as evidenced by polarized infrared spectroscopy.
In conjunction with relevant residue substitutions a
potential link with physiology has been established based
on the fact that, in a way reminiscent to low-pH-induced
fusion activation, synthetic HA FPs interact with mem-
branes more efficiently at acid than at neutral pH. However,
conflicting results have been reported, indicating that factors
such as peptide length, peptide modifications, selected
representative viral strain and model membrane composition
may affect the pH dependence of membrane interactions.
For instance, while a synthetic GLFGAIAGFIEGGWTG-
MIDG peptide representing the HA FP from A/PR/8/34
strain was shown by Murata et al. [83] to associate with
and induce pH-dependent inter-vesicle lipid-mixing in PC
SUV, this dependence on pH was not reproduced by Lear
and DeGrado [84] using a closely related but different
GFFGAIAGFLEGGWEGMIAG sequence derived from the
B/Lee/40 strain. These authors found significant binding
and fusion induced by the peptide also at neutral pH.
However, interactions with vesicles appeared strengthened
at acidic pHs since both, helicity increase and a blue shift of
the Trp fluorescence emission maximum, occurred after
lowering the pH. Wharton et al. [77] found the syntheticFP-membrane interaction to be pH-dependent only when
Chol-containing SUV were used. Synthetic peptides repre-
senting the wild-type sequence were found to induce PC
SUV fusion and leakage both at neutral and acidic pH.
However, this effect was clearly pH-dependent when larger
PC/Chol vesicles were used instead. Synthetic 7-aa-long
sequences did not respond to acidification of the medium in
their capacity to insert into planar bilayers and LUV [78].
Rafalski et al. [79] found that efficient insertion into
LUV of synthetic 20-residue peptides representing X31 HA
FPs required acid pH to evolve. These authors underscored
several factors that might condition the different pH-depen-
dence observed for in vitro detected interactions. For in-
stance, the number of ionizable groups among the four C-
terminal residues may affect pH-dependent insertion. The
low-pH-dependent peptides derived from A/PR/8/34 and
X31 strains contain several ionizable groups within that
stretch. In contrast, the electrically neutral carboxy end
probably stabilizes more readily perturbing helical confor-
mations in peptides derived from the B/Lee strain, even at
neutral pH. This is also consistent with the fact that a shorter
17-aa-long peptide permeabilized PC LUV at neutral and
acid pH with almost equal potency [85].
The NMR-solved structures provide structural grounds
for a low-pH-induced transition of HA FP bound to lipids,
which might be related to the promotion of bilayer destabi-
lization [33]. At both neutral and acid pHs, the structure
displays an oblique N-terminal amphipathic helix spanning
residues 2–10 and a turn stabilized by H-bonds that
redirects the C-terminal portion of the chain (Fig. 1). The
C-terminal region structure and orientation relative to the N-
terminal helix differ at pH 5 from those at neutral pH. A new
network of H-bonds together with an increased hydropho-
bicity of the membrane-core facing surface result in the two
arms of the kinked structure closing further and inserting
more deeply into the membrane. This effect is postulated to
increase the lateral pressure within the hydrocarbon core and
interfacial regions of the membrane monolayer.
An important argument against the relevance of low pH
dependence of FP membrane association stems from the fact
that the optimum pH of fusion induced by HA always
correlates with the optimum pH of its conformational
change [76]. No HA has been described so far whose
optimal pH of fusion is limited by the optimal pH found
for synthetic FP–membrane interaction. Nevertheless, it is
possible that certain FP sequences have evolved to become
more hydrophobic and fusion-competent, specifically at the
pHs they get exposed to the medium.
Finally, it should be mentioned that HA2 FP has been used
in gene transfer [86]. Complexes containing plasmid DNA,
transferrin–polylysine conjugates and polylysine-conjugated
HA2 fusion peptides have been used to transfect different cell
lines with expression gene markers. While transferrin is used
as a ligand to direct uptake through receptor-mediated endo-
cytosis, the FP is expected to disrupt the endosomal mem-
brane and promote DNA release from endosomes. The
Fig. 3. (A) Penetration of HIV-1 FP sequences into PG monolayers.
Maximum increase in surface pressure was measured as a function of the
initial pressure of the phospholipid monolayer, upon injection in the
subphase of V2E mutant-like NH2-AEGIGALFLGFLGAAGSTMGAAS-
CONH2 sequence (o) or a corresponding wt-like NH2-AVGIGALFLGFL-
GAAGSTMGARS-CONH2 functional peptide (.). At the concentrations
used (0.27 AM), peptide alone induced in both cases surface pressure
increases below the minimum k0 tested. (B) Stern–Volmer plot of Trp
fluorescence quenching by increasing concentrations of acrylamide in
buffer (D) and in the presence of PG LUV (.) or SUV (o). Lipid
concentration was 200 AM and peptide-to-lipid molar ratio, 1:200. In these
experiments, F8W analogs of previous V2E and wt sequences were used.
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competence to interact with and permeabilize liposomes in
a pH- and sequence-dependent fashion. Its inclusion also
resulted in a considerable increase in the efficiency of
transferrin–polylysine complexes to mediate gene delivery.
Moreover, a close correlation was found between the content
of peptide within a complex, percentage of induced liposomal
leakage and increase in gene expression. Thus, cell mem-
brane interactions of isolated FP sequences reproduce, at least
in part, several aspects of viral entry events.
3.2. HIV-1 gp41 peptides
gp41 FP mutations have been described that specifically
affect post-activation membrane merger steps. A mutational
analysis by Freed et al. [87] showed that polar substitutions
completely abolished syncytium formation induced by the
surface expression of HIV-1 env products in transfected
HeLa T4 cells. Subsequently, it was shown that one of the
described polar substitutions comprising the replacement of
hydrophobic Val at position 2 by negatively charged Glu
residue, resulted in an inactive gp41 envelope subunit that
interfered with both syncytium formation and infection
mediated by the wild-type glycoprotein [88].
The ability of the HIV-1 FP to penetrate into membranes
was first studied by Rafalski et al. [89] using 23-mer synthetic
AVGIGALFLGFLGAAGSTMGARS peptides and PG
membranes. These authors showed that these peptides were
capable of penetrating lipid monolayers and inducing per-
meabilization of LUV. In contrast to the wt-like sequence, a
peptide bearing the V2E polar substitution was later demon-
strated to be unable to destabilize PG vesicles [90]. One
interesting finding in that study was that the active peptide, in
contrast to the inactive one, was able to adopt a h structure in
the membrane, in the presence of cations. Fusion of lip-
osomeswith different lipid compositions was also completely
abolished by the V2E polar substitution [35,55,91]. However,
the wt- and mutant-like sequences seemed to associate to the
same extent to vesicles, as inferred from binding assays.
Mobley et al. [30] reported that V2E substitution also reduced
the ability of the wt-like sequence to induce hemolysis and
fusion of erythrocyte ghosts. Interestingly, a different polar
substitution (L9R) described by Freed et al. [87] as producing
a blocking phenotype, had a more pronounced effect.
Inclusion of a negatively charged residue in position 2
may anchor the N-terminus at the membrane interface and
interfere with further penetration into the hydrophobic
milieu, thus inactivating the sequence. Indeed, whereas
surface-bound 1-(4-trimethylaminophenyl)-6-phenyl-1,3,5-
hexatriene (TMA-DPH) emission anisotropy was unaffected
by mutant and functional peptides, emission anisotropy of
membrane-buried 1,6-diphenyl-1,3,5-hexatriene (DPH) was
increased only by the fusogenic sequence, both in neutral
[35] and negatively charged vesicles (Pereira and Nieva,
unpublished observations). The results in Fig. 3 and Table 1
further illustrate this point.The different penetration behavior of wt- and mutant-like
peptides depending on the initial lateral pressure of a lipid
monolayer (k0) is shown Fig. 3A. The monolayer exclusion
pressures, kex, or the maximum initial lateral pressures at
which membrane-association was accompanied by peptide
integration into the monolayer [92] were 29.1 and 39.2 mN
m 1 for mutant- and wild-type peptides, respectively. Thus,
the inactive V2E variant was unable to penetrate mono-
layers at lateral pressures postulated to arise from the lipid
packing density of biological membranes and LUV
(k0z 30–35 mN m 1, Ref. [80]) but penetrated at lateral
pressures existing in the external monolayer of SUV
(k0f 20–25 mN m 1, Ref. [80]). Accordingly, results in
Table 1 indicate a shift in Trp emission of F8W analogs
towards shorter wavelengths in the presence of SUV and
LUV for the wt-like sequence. A comparable shift for V2E
sequence is only observed in presence of SUV. The degree
of solvent exposure of the Trp residues in these samples can
be inferred from the results obtained using the aqueous
quencher acrylamide (panel 3B). The Stern –Volmer
quenching constants (KSV) obtained from the plots (Table
Table 1
Maximum emission wavelengths (nm) and Stern–Volmer quenching
constants (M 1) for F8W variants of HIV-1 fusion peptides
Peptide No liposomes POPG LUVa POPG SUVa
kmax KSV kmax KSV kmax KSV
wtb 350 21.5 326 5.8 325 4.8
V2E 350 17.6 347 13.7 326 8.8
a The peptide-to-lipid mole ratios were 1:200.
b Sequences designated as in caption for Fig. 2.
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Trp residue was significantly reduced in both peptides when
associated to vesicles. However, the degree of protection
from the solvent induced by PG vesicles was lower for the
V2E sequence in the presence of LUV. In essence, these
data demonstrate that HIV-1 FP V2E and influenza FP G1E
N-terminal polar substitutions might provoke a similar
blocking effect on peptide penetration into membranes.
An additional aspect of V2E substitution-induced inter-
ference was noted by Kliger et al. [55] using 33-aa-long
versions of the FP: even if both, wt- and mutant-like
sequences, penetrated efficiently into SUV membranes,
and self-assembled within, only the wt sequence induced
efficient destabilization of these vesicles. This is an impor-
tant observation because it suggests that the V2E variant is
restricted in its interaction with membranes downstream to
effective penetration. The different perturbing abilities of the
peptides were proposed to result from the different abilities
of the sequences to oligomerize. Only the wt-like sequence
gave rise to the formation of high order complexes as
evidenced by SDS-PAGE.
It is noteworthy here that G1E substitution was also
shown to not impair intact HA [22] or synthetic FP [47,79]
association with SUV, while the membrane perturbations
induced by the wt-like sequence were abrogated. Moreover,
Longo et al. [75] identified a pore-formation activity of the
functional FP well below the membrane rupture tensions
caused by simple transfer of mass to the bilayers. Thus, the
ability to perturb the bilayer architecture after insertion
seems to be an intrinsic feature of functional viral FPs
which probably requires the adoption of structurally defined
oligomeric complexes in membranes, most likely formed
after insertion.
Evidence for specific HIV-1 FP structures required for
fusion activity was provided by the mutagenesis study of
Schaal et al. [93]. These authors produced gp41 mutant
molecules with N-terminal deletions of increasing lengths.
The efficiency of cell–cell fusion activity decreased until it
was completely lost with deletion of five amino acids. In
addition, the mutants with reduced fusion activity showed
dominant interference in co-transfection assays, in a way
similar to that displayed by the V2E substitution [88]. This
indicates that the first amino acids are dispensable for the
oligomerization process, but the preservation of N-terminal
identity may be required for optimal fusion. Synthetic
peptides representing active and inactive sequences de-scribed in this study were later assayed in their capacity to
induce lipid mixing and leakage of LUV [45]. Abrogation of
fusion in transfected cells correlated with impairment in the
ability to perturb vesicles [45] and erythrocyte membranes
[30].
To test whether conserved Gly residues scattered along
the FP sequence play a role in HIV-1 fusion, Delahunty et al.
[94] conducted a mutational analysis using transfected cell–
cell fusion functional assays. Gly10 and Gly13 residues were
found to be critical for activity. In addition Phe8 and Phe11
within the canonical FLGFLG sequence were found to be
important for optimal fusion activity. A combined structure–
function study later focused on the effects of replacing Phe11
with Val or Gly [58]. The F11V substitution reduced fusion
activity of the whole protein assayed in a cell–cell fusion
system but did not abolish it. In contrast, F11G substitution
almost completely impaired gp41 fusion activity. Synthetic
peptides bearing equivalent substitutions were, respectively,
ca. 50% and 100% less fusogenic when assayed in a
vesicular system. Fusion activity also correlated with the
ability of these sequences to form high order complexes as
evidenced by SDS-PAGE, but not with other physicochem-
ical properties such as adopted secondary structure or self-
assembly in lipidic environments.
Formation of specific membrane-embedded complexes
might also explain the inhibitory effect displayed by HIV-1
FPs in cell systems. A hexapeptide which was identical in
amino acid sequence to the gp41 N-terminus was found by
Owens et al. [95] to completely inhibit syncytium formation
mediated by HIV-1 envelope glycoproteins expressed at the
surface of HeLa CD4+ cells. The inhibitory effect was
sequence-specific and dose-dependent. These authors sug-
gested that the inhibitors might interact with its homologous
FP sequence at gp41 thereby preventing its normal fuso-
genic function. Longer HIV-1 FPs inhibited HIV-induced
syncytium formation and antigen production in infected
cells [96]. Solubilization by conjugating the peptide with
charged polymers at its C-terminus resulted in augmentation
of the inhibitory capacity, while blocking of N-terminus by
conjugation with charged polymers hampered the inhibitory
capacity of the peptide. Kliger et al. [55] demonstrated
inhibition of cell–cell fusion induced by expressed gp120/
41 using 33-mer sequences representing gp41 N-terminus.
A functional feature of these sequences was shown to be
their capacity to assemble high order complexes.
HIV-1 FP has been used as well as a component of
complexes designed for intracellular delivery. A chimerical
peptide derived from the hydrophobic fusion peptide of
HIV-1 gp41 and the hydrophilic nuclear localization se-
quence of SV40 large T antigen, could also be used for the
delivery of oligonucleotides and plasmids into cultured cells
[97]. This construct interacts with nucleic acids and protects
them from degradation in culture media [98]. The role of the
gp41 FP within the conjugate has been ascribed to the
promotion of translocation directly through the cell mem-
brane, i.e., independently of the endocytic pathway. In fact,
Fig. 4. Fluorescence emission spectra (kex = 295 nm) of SFV FPs at
different pHs (indicated in panels), in buffer (dotted lines), and incubated
with PC/PE/Chol (1:1:1) LUV (continuous lines). 21-mer: NH2-YQCK-
VYTGVYPFMWGGAYCFC-CONH2 23-mer: NH2-DYQCKVYTG-
VYPFMWGGAYCFCD-CONH2. Dashed lines correspond to spectra
obtained using G91D representing NH2-YQCKVYTGVYPFMWDG-
AYCFC-CONH2 (21-mer) and NH2-DYQCKVYTGVYPFMWDG-
AYCFCD-CONH2 (23-mer) sequences. For comparison, spectra in buffer
for wt- and G91D-representing sequences were normalized to the same
emission values. Peptide concentration was 1 AM and, in vesicle samples,
the peptide-to-lipid ratio was 1:100.
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after internalization. Thus, complexes containing FPs seem
to penetrate into cells in a way reminiscent to that of whole
virions.
3.3. Sendai F peptides
Many substitutions in the conserved amino acids of SV5
fusion domain are tolerated without loss of syncytium
formation activity [14]. In particular, GlyAla substitu-
tions exhibited increase in fusion activity in transfected
cells. Since other mutations caused increase in hydropho-
bicity but did not exhibit enhanced fusogenic activity, it was
claimed that Gly residues might lessen the potential of the
FP to form a fusion-competent a-helical structure.
A peptide representing the Sendai fusion domain as well
as one variant containing a G12A substitution were later
investigated in their ability to bind to membranes and to
induce inter-vesicle fusion [54]. The G12A substitution
dramatically increased the fusogenic activity of the peptide,
as well as its ability to aggregate membranes. Thus, in vitro
lipid mixing induced by these peptides reproduced the
syncytium formation results by mutant F proteins. Interest-
ingly, the observed different membrane-aggregating and
fusogenic potencies could not be explained in terms of
different membrane affinities, adopted conformations or
self-aggregation at membrane surfaces. The main differ-
ences observed between both sequences were the degree of
penetration, shallower for the wt-representing sequence.
3.4. Internal SFV FP
In comparison to N-terminal FPs, little is known on the
insertion mechanism of FPs that are internal sequences of
the polypeptide chain [2]. A paradigmatic case of internal
FP is the fusion domain of the Semliki forest virus (SFV)
spike protein [99]. SFV FP has been mapped to residues
75DYQCKVYTGVYPFMWGGAYCFCD97 of E1 subunit
and occupies a loop at the tip of its distal domain [100].
Similarly to influenza, SFV penetrates into cells through
receptor-mediated endocytosis. Exposure to the low pH
present in the lumen of late endosomes activates E1-medi-
ated fusion of virions with the membrane of these organ-
elles. The role of the FP in this process was evaluated
through mutagenesis of a spike protein cDNA [99,101,102].
Several mutations were studied in transfected cell–cell
fusion assays. In particular, a polar G91D substitution was
found to completely block cell–cell fusion activity without
affecting spike protein assembly or transport.
In Fig. 4, we analyze the membrane-interacting abilities
of 23-aa-long synthetic peptides representing SFV FP as
compared to those of a shorter 21-mer derivative lacking the
two C- and N-terminal Asp residues. The fluorescence
spectra have been obtained utilizing wt- and G91D-like
sequences at neutral (7.4) and acid (5.5) pHs. Intrinsic
fluorescence of the 21-mer wt-like sequence was found toincrease at both pHs in the presence of vesicles, suggesting
that the single Trp residue penetrates into the bilayer
hydrophobic milieu in both cases. In contrast, the 23-mer
reduced its emission intensity at neutral pH upon contact
with vesicles, while the opposite effect was observed at low
pH. This would be consistent with superficial association
and further penetration at neutral and acid pHs, respectively.
By comparison, fluorescence of G91D-representing 21- and
23-mer sequences did not appreciably change in presence of
vesicles at any pH. Our data suggest that deep insertion into
a low polarity environment could only be achieved by wt-
representing sequences. In addition, the presence of flanking
Asp residues may condition penetration at low pH. These
observations imply that the interactions of internal SFV FP
with model membranes might resemble in certain aspects
those of N-terminal HA FP [47,79].4. Assisted fusion
Some of the most crucial factors compromising mem-
brane stability reside upon the bilayer lipid–water interface
and polar headgroup region. At that level, the forces govern-
ing the processes of membrane–membrane interaction and
deformability exert much of their action [103]. Given their
phospholipid composition, rich in highly hydrated lamellar-
type species, bilayers to be fused during viral infection are
considered to be refractory to merger. Thus, it is conceivable
that FP activity must be assisted in order to modulate the
aggregational state of merging bilayers.
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PG LUV was shown to become fusogenic in the presence of
cations [56]. Addition of Ca2 + or Mg2 + to this system
promoted peptide-induced fusion of PG liposomes by sup-
porting aggregation. The occurrence of fusion was sup-
ported by the irreversible increase in size of the vesicles
observed when the FP was added to a vesicle mixture
containing 5 mM Ca2 +. The size distribution of the vesicle
population (ca. 100 nm) indicated that the mean diameter
did not change significantly when the vesicles were treated
with 5 mM Ca2 + for 10 min and then 10 mM EDTA was
added. However, addition of HIV-1 FP after the addition of
Ca2 +, resulted in an increase of the mean vesicle diameter to
ca. 700 nm, as determined after the addition of EDTA. The
lipid-mixing kinetics analyzed using a mass-action kinetic
model indicated that, at a fixed Ca2 + and lipid concentra-
tion, increasing the amount of peptide increased the rate
constant of fusion. These observations confirmed that the
peptide per se constitutes the fusogenic agent in the system.
Following a different strategy, Haque et al. [104] assisted
HA FP-induced fusion by aggregating PC vesicles with
poly(ethylene glycol). Interestingly, the presence of the FP
did promote lipid-mixing and leakage of DOPC LUV, but
not the mixing of the vesicular aqueous contents. This
emphasizes that in the absence of the HA TMD, the action
of the FP might be restricted to the mixing of lipids of
interacting bilayers [105].
A relatively new hypothesis postulates that initial mo-
lecular events of viral fusion might involve the concerted
action of several fusion protein segments interacting with
membranes (reviewed in Ref. [53], see also specific chapter
in this issue). Thus, the existence in soluble ectodomains of
additional regions implied in membrane interactions sug-
gests that more than one protein segment may have a role in
the fusion process [106,107]. This also implies that FPs
might be assisted in their fusogenic activity by these
regions.5. Concluding remarks
Insertion into target membranes is the common theme
among the proposed functions of viral FPs. N-terminal G1E
and V2E polar substitutions in influenza and HIV-1 FPs,
respectively, impair penetration at the lateral pressures exist-
ing in biological membranes (Ref. [79], Fig. 3). The packing
state of lipids at the local point where the fusion event
develops is not known with certainty, and insertion of these
mutant sequences into strained bilayers cannot be excluded.
Nevertheless, insertion into membranes is not enough to
produce the perturbations that functional FPs induce in
model systems. The aforementioned substitutions do not
preclude insertion of whole proteins and isolated synthetic
FPs into SUV, but hamper the ability of the functional
sequences to induce leakage and fusion [22,47,55,77,79].
This suggests that in addition to their function as conditional‘‘secondary’’ TMDs, fusion-competent FPs must fulfill other
functions that are primarily reflected in their capacity to
destabilize the bilayer organization.
The membrane perturbations generated by FPs seem to
originate from their capacity to form pores and lower bilayer
rupture tension [74,75]. The former effect may result in the
permeabilization of dispersed vesicles while the latter may
lead to fusion of aggregated membranes through the promo-
tion of non-lamellar intermediates with defined geometry. It
is possible that both effects arise as a consequence of a
common topology and conformation adopted by FPs in the
membrane: an amphipathic helix obliquely inserted into one
membrane monolayer that is followed by a kink region
[33,41]. An oblique angle has been observed for mem-
brane-inserted sequences representing functional helical
regions of influenza and HIV-1 FPs (see specific chapter in
the same issue). Although necessary, an oblique angle does
not seem to be sufficient to attain the functional structure in
membranes since several non-functional HA FPs do adopt
oblique angles but are unable to induce membrane perturba-
tions [27,47]. On the other hand, the kinked region has not
been systematically studied so far and the functional signif-
icance of this structure is yet unknown. In this regard, a
particularly intriguing observation is that E11V and E15V
substitutions in HA FP (Fig. 1) do not significantly affect
fusion activity [26,82].
The induction of fusion requires previous close apposi-
tion of membranes. It seems that when a particular lipid
composition does not bear an intrinsic tendency to aggregate
[103], FPs must be assisted in order to induce fusion. Model
membrane aggregation has been facilitated using cations
[56,90] and more recently poly(ethylene glycol) [104]. It is
possible that other regions of the glycoproteins as the helical
heptad repeats also assist fusion by acting as linkers that
facilitate inter-vesicle contacts [105,108–110]. An alterna-
tive, and perhaps complementary, possibility is that these
regions actively participate in vesicle perturbation together
with the FPs. Thus, these stretches immersed into the
surface monolayer might contribute to destabilization and
merger of the contacting bilayers [53].
Finally, from the experimental studies using synthetic
sequences and model membranes that we have described
here, it remains unclear how FPs may contribute to fusion
pore opening [22–24]. The approximate four-residue spac-
ing found for Gly residues in FPs might be related to this
function [76]. The fact that FPs may assemble oligomeric
structures in membranes suggests a certain degree of mo-
lecular recognition in which Gly residues might play a direct
role. An attractive hypothesis is that eventual opening of the
fusion pore is concomitant to the formation of unidentified
membrane-embedded protein structures. These structures
would be oligomeric in nature and more likely include
FPs and transmembrane regions of the fusion glycoproteins.
Identification and characterization of those possible organ-
izations might help in unraveling the mechanisms of fusion-
inhibition by FP-representing sequences [55,95,96], as well
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systematic rationalization [21,76].
In conclusion, synthetic FPs are good models to study
membrane-associated structures and processes functioning
in viral fusion. Assessment of these sequences in model
systems has made possible the identification of bilayer
perturbations that are specifically promoted by synthetic
peptides representing functional FPs. In addition, systematic
structure–function analyses based on new structural para-
digms of membrane-bound FPs (Fig. 1) will provide a clearer
picture on the roles played by these viral sequences during
fusion. A landmark finding in this research area is that
functional FP-promoted bilayer perturbations are probably
required but not sufficient for the occurrence of viral fusion
in the physiological context, i.e., that FP action is probably
assisted in order to lead these initial processes towards
formation of a functional fusion pore. The unraveling of
these assistance mechanisms in terms of membrane lipid and
fusion protein sequence contributions will definitely benefit
from experimental characterization in model systems.Acknowledgements
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